Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Oculomotor palsy that arises from lesions in the supranuclear pathways controlling extraocular movement.
Biomarker and diagnostic research for supranuclear oculomotor palsy has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
195 publications have been identified in PubMed for supranuclear oculomotor palsy. Kisho has analyzed 130 by research type. Research spans Basic Science / Preclinical (30%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 39 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 3:02 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 33 | 25% |
Testing and diagnosis research | 23 | 18% |
Disease patterns and progression | 19 | 15% |
Patient case studies | 8 | 6% |
Clinical study results | 5 | 4% |
New treatment approaches | 2 | 2% |
Other research | 1 | 1% |
Painous C (2026). [PMID: 41159477](https://pubmed.ncbi.nlm.nih.gov/41159477/). *Movement disorders : official journal of the Movement Disorder Society*. [Epidemiology / Natural History]
Zitser J (2026). [PMID: 40152909](https://pubmed.ncbi.nlm.nih.gov/40152909/). *Brain*. [Review / Meta-Analysis]
Agarwal S (2026). [PMID: 30252354](https://pubmed.ncbi.nlm.nih.gov/30252354/). *Unknown Journal*. [Review / Meta-Analysis]
Kukkle PL (2026). [PMID: 40898879](https://pubmed.ncbi.nlm.nih.gov/40898879/). *Movement disorders clinical practice*. [Review / Meta-Analysis]
Jellinger KA (2026). [PMID: 40794238](https://pubmed.ncbi.nlm.nih.gov/40794238/). *J Neural Transm (Vienna)*. [Review / Meta-Analysis]
Ono D (2026). [PMID: 41830446](https://pubmed.ncbi.nlm.nih.gov/41830446/). *Ann Neurol*. [Diagnostic / Biomarker]
Giannakis A (2026). [PMID: 40445321](https://pubmed.ncbi.nlm.nih.gov/40445321/). *J Neural Transm (Vienna)*. [Review / Meta-Analysis]
Bhate M (2026). [PMID: 41001820](https://pubmed.ncbi.nlm.nih.gov/41001820/). *J Pediatr Ophthalmol Strabismus*. [Review / Meta-Analysis]
Baschieri F (2026). [PMID: 40948294](https://pubmed.ncbi.nlm.nih.gov/40948294/). *Mov Disord Clin Pract*. [Epidemiology / Natural History]
Kumar M (2026). [PMID: 41616780](https://pubmed.ncbi.nlm.nih.gov/41616780/). *Cell*. [Basic Science / Preclinical]
AI-curated news mentioning supranuclear oculomotor palsy
Updated Mar 12, 2026
A recent literature review highlights congenital cyclic oculomotor palsy and spasms, presenting two new cases that contribute to the understanding of this rare condition. This study may inform future research and clinical approaches.